Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.2.19 (
ubiquitin-protein ligase
)
799
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Inhibitor of apoptosis (IAP) proteins suppress apoptosis and inhibit caspases. Several IAPs also function as ubiquitin-protein ligases. Regulators of IAP auto-ubiquitination, and thus IAP levels, have yet to be identified. Here we show that Head involution defective (Hid), Reaper (Rpr) and Grim downregulate Drosophila melanogaster IAP1 (DIAP) protein levels. Hid stimulates
DIAP1
polyubiquitination and degradation. In contrast to Hid, Rpr and Grim can downregulate
DIAP1
through mechanisms that do not require
DIAP1
function as a
ubiquitin-protein ligase
. Observations with Grim suggest that one mechanism by which these proteins produce a relative decrease in
DIAP1
levels is to promote a general suppression of protein translation. These observations define two mechanisms through which
DIAP1
ubiquitination controls cell death: first, increased ubiquitination promotes degradation directly; second, a decrease in global protein synthesis results in a differential loss of short-lived proteins such as
DIAP1
. Because loss of
DIAP1
is sufficient to promote caspase activation, these mechanisms should promote apoptosis.
...
PMID:Hid, Rpr and Grim negatively regulate DIAP1 levels through distinct mechanisms. 1202 67
Although loss of the inhibitor of apoptosis (IAP) protein
DIAP1
has been shown to result in caspase activation and spontaneous cell death in Drosophila cells and embryos, the point at which
DIAP1
normally functions to inhibit caspase activation is unknown. Depletion of the
DIAP1
protein in Drosophila S2 cells or the Sf-IAP protein in Spodoptera frugiperda Sf21 cells by RNA interference (RNAi) or cycloheximide treatment resulted in rapid and widespread caspase-dependent apoptosis. Co-silencing of dronc or dark largely suppressed this apoptosis, indicating that
DIAP1
is normally required to inhibit an activity dependent on these proteins. Silencing of dronc also inhibited DRICE processing following stimulation of apoptosis, demonstrating that DRONC functions as an apical caspase in S2 cells. Silencing of diap1 or treatment with UV light induced DRONC processing, which occurred in two steps. The first step appeared to occur continuously even in the absence of an apoptotic signal and to be dependent on DARK, because full-length DRONC accumulated when dark was silenced in non-apoptotic cells. In addition, treatment with the proteasome inhibitor MG132 resulted in accumulation of this initially processed form of DRONC, but not full-length DRONC, in non-apoptotic cells. The second step in DRONC processing was observed only in apoptotic cells. These results indicate that the initial step in DRONC processing occurs continuously via a DARK-dependent mechanism in Drosophila cells and that
DIAP1
is required to prevent excess accumulation of this first form of processed DRONC, presumably through its ability to act as a
ubiquitin-protein ligase
.
...
PMID:The Drosophila DIAP1 protein is required to prevent accumulation of a continuously generated, processed form of the apical caspase DRONC. 1239 80